Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

1,662 public trials 323 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

A Study of Melphalan Flufenamide (Melflufen) Plus Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

NCT02963493

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Innovative Clinical Research Institute (ICRI) Whittier, California, United States
  • University of Florida Gainesville, Florida, United States
  • RUSH Chicago, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 20 locations
View Trial Details
Completed

A Study of PRT1419 in Patients With Relapsed/Refractory Hematologic Malignancies

NCT04543305

Conditions
Acute Myeloid Leukemia, Blood Protein Disorders, Bone Marrow Diseases, +22 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Florida Cancer Specialists Lake Mary, Florida, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients

NCT01568866

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Providence St. Joseph Medical Center Burbank, California, United States
  • UCSD Moore Cancer Center La Jolla, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Central Coast Medical Oncology Group Santa Maria, California, United States
View all 241 locations
View Trial Details
Completed

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

NCT01345019

Conditions
Blood Protein Disorders, Bone Diseases, Bone Marrow Diseases, +34 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Fayetteville, Arkansas, United States
  • Research Site Anaheim, California, United States
  • Research Site Campbell, California, United States
View all 309 locations
View Trial Details
Completed

Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)

NCT01575925

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Female Urogenital Diseases, +20 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Ingalls Cancer Research Center Harvey, Illinois, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details
Completed

An Investigational Immuno-therapy Trial of Pomalidomide and Low-dose Dexamethasone With or Without Elotuzumab to Treat Refractory and Relapsed and Refractory Multiple Myeloma (ELOQUENT-3)

NCT02654132

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Winship Cancer Institute Atlanta, Georgia, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Investigative Clinical Research Of Indiana, Llc Indianapolis, Indiana, United States
  • Beth Israel Comprehensive Cancer Center Boston, Massachusetts, United States
View all 55 locations
View Trial Details

Related conditions